» Articles » PMID: 24497601

Outcomes of Peritoneal Dialysis Patients and Switching to Hemodialysis: a Competing Risks Analysis

Overview
Journal Perit Dial Int
Publisher Sage Publications
Date 2014 Feb 6
PMID 24497601
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We performed a review of a large incident peritoneal dialysis cohort to establish the impact of current practice and that of switching to hemodialysis.

Methods: Patients starting peritoneal dialysis between 2004 and 2010 were included and clinical data at start of dialysis recorded. Competing risk analysis and Cox proportional hazards model with time-varying covariate (technique failure) were used.

Results: Of 286 patients (median age 57 years) followed for a median of 24.2 months, 76 were transplanted and 102 died. Outcome probabilities at 3 and 5 years respectively were 0.69 and 0.53 for patient survival (or transplantation) and 0.33 and 0.42 for technique failure. Peritonitis caused technique failure in 42%, but ultrafiltration failure accounted only for 6.3%. Davies comorbidity grade, creatinine and obesity (but not residual renal function or age) predicted technique failure. Due to peritonitis deaths, technique failure was an independent predictor of death hazard. When successful switch to hemodialysis (surviving more than 60 days after technique failure) and its timing were analyzed, no adverse impact on survival in adjusted analysis was found. However, hemodialysis via central venous line was associated with an elevated death hazard as compared to staying on peritoneal dialysis, or hemodialysis through a fistula (adjusted analysis hazard ratio 1.97 (1.02 - 3.80)).

Conclusions: Once the patients survive the first 60 days after technique failure, the switch to hemodialysis does not adversely affect patient outcomes. The nature of vascular access has a significant impact on outcome after peritoneal dialysis failure.

Citing Articles

Regression of Left Ventricular Hypertrophy in Patients Combined with Peritoneal Dialysis and Hemodialysis.

Luyan G, Haixia Z, Sheng F, Gang S, Jing Z, Ying L Int J Clin Pract. 2022; 2022:2652380.

PMID: 36518909 PMC: 9719434. DOI: 10.1155/2022/2652380.


Hyperspectral evaluation of vasculature in induced peritonitis mouse models.

Stergar J, Lakota K, Perse M, Tomsic M, Milanic M Biomed Opt Express. 2022; 13(6):3461-3475.

PMID: 35781958 PMC: 9208583. DOI: 10.1364/BOE.460288.


Increased risk of modality failure with higher serum uric acid level in continuous ambulatory peritoneal dialysis patients: a prospective cohort study.

He S, Xiong Q, Li L, Lin X, Zhao J, Guo X Ren Fail. 2022; 44(1):272-281.

PMID: 35172675 PMC: 8856069. DOI: 10.1080/0886022X.2022.2035762.


Optimization of Dialysis Modality Transitions for Improved Patient Care.

Imbeault B, Nadeau-Fredette A Can J Kidney Health Dis. 2019; 6:2054358119882664.

PMID: 31666977 PMC: 6798163. DOI: 10.1177/2054358119882664.


Hemodialysis Internal jugular vein versus Subclavian vein Catheters: Complications, patients' comfort, tolerance and cost-effectiveness.

Shafique M, Akhtar S, Mahnoor M, Hussain M Pak J Med Sci. 2019; 35(1):124-128.

PMID: 30881409 PMC: 6408634. DOI: 10.12669/pjms.35.1.249.


References
1.
Lee H, Park H, Seo B, Do J, Yun S, Song H . Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance). Perit Dial Int. 2005; 25(3):248-55. View

2.
Han S, Ahn S, Yun J, Tranaeus A, Han D . Mortality and technique failure in peritoneal dialysis patients using advanced peritoneal dialysis solutions. Am J Kidney Dis. 2009; 54(4):711-20. DOI: 10.1053/j.ajkd.2009.05.014. View

3.
Johnson D, Hawley C, McDonald S, Brown F, Rosman J, Wiggins K . Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2010; 25(6):1973-9. DOI: 10.1093/ndt/gfp780. View

4.
Mehrotra R, Chiu Y, Kalantar-Zadeh K, Bargman J, Vonesh E . Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med. 2010; 171(2):110-8. DOI: 10.1001/archinternmed.2010.352. View

5.
Mortier S, Faict D, Schalkwijk C, Lameire N, De Vriese A . Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane. Kidney Int. 2004; 66(3):1257-65. DOI: 10.1111/j.1523-1755.2004.00879.x. View